Over the past few years, considerable progress has been made in the identification of regulatory T cell pathways and factors that act as mediators between T cell subsets involved in these pathways (1-3). However, at least two important aspects of regulation of the immune response have remained largely unexplored. One of them is the role of antigen presentation and of major histocompatibility complex (MHC)1 restriction in the activation of suppressor T (Ts) cells. From the paucity of reports on MHC restriction of Ts sets (4-8), one would conclude that MHC-restricted antigen presentation is not essential for the activation of most suppressor pathways. This view gains support from the demonstrated high affinity of some Ts cells for free antigen (9-11). It is, however, equally possible that the uncertainties about MHC restriction in Ts systems reflect the absence of an appropriate experimental model in which the interaction of Ts cells with antigen-presenting cells (APC) could be explored.
Over the past few years, considerable progress has been made in the identification of regulatory T cell pathways and factors that act as mediators between T cell subsets involved in these pathways (1-3). However, at least two important aspects of regulation of the immune response have remained largely unexplored. One of them is the role of antigen presentation and of major histocompatibility complex (MHC)1 restriction in the activation of suppressor T (Ts) cells. From the paucity of reports on MHC restriction of Ts sets (4) (5) (6) (7) (8) , one would conclude that MHC-restricted antigen presentation is not essential for the activation of most suppressor pathways. This view gains support from the demonstrated high affinity of some Ts cells for free antigen (9) (10) (11) . It is, however, equally possible that the uncertainties about MHC restriction in Ts systems reflect the absence of an appropriate experimental model in which the interaction of Ts cells with antigen-presenting cells (APC) could be explored.
The second aspect that appears to be neglected is the mechanism of interaction between Ts effector cells and their targets. The mode of action of suppressor-effector factors is largely unknown (12) (13) (14) , and, to our knowledge, there is only one report in the literature that bears on the direct interaction between Ts cells and T helper (Th) cells (15) .
Our recent work on the proliferative T cell response to lactate dehydrogenase B (LDHB) has provided a system suitable to study the questions outlined above. We have demonstrated (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) that most H-2 haplotypes respond to LDHB and that the T cell proliferation in all responder haplotypes is restricted by the molecule controlled by the A~ and A~ loci in the I-A region of H-2 (A [A~Aa] molecules). The proliferating cells are most likely Th cells because their genetic control is almost identical with that of antibody production to LDHB (16, 19) . Nonresponder haplotypes to LDHB include virtually all strains that carry the k allele at the E~ and E~ loci of the H-2 complex. However, nonresponsiveness can be reversed by in vivo or in vitro administration of monoclonal antibodies against the molecule controlled by the E~ locus in the I-A and the E~ locus in the I-E region of H-2 (E k molecule). Furthermore, primed nonresponder T cells depleted of Lyt-2-bearing cells give an A-restricted proliferative response upon challenge with LDHB in vitro (16) (17) (18) 20) . The suppression observed in Ek-bearing nonresponder strains is LDHB specific, and expression of the E k molecule on the APC is necessary for its manifestation (20) . Thus, we have a system where the target of suppression is an A-restricted Th cell; the suppression can be measured as inhibition of Th cell proliferation, and at least one of the Ts cell subsets involved is E ~ restricted. The two main participating cell sets also differ in terms of their Lyt phenotypes.
In this communication, we characterize the cells involved in the LDHB suppressor pathway and describe the interactions between them, with particular emphasis on Ts-Th interaction.
Materials and Methods
Mice. Female and male mice, 8-12 wk of age, were obtained from our colony at the Max Planck Institute for Biology. The strains used and their alleles at H-2 loci are listed in Tables  III and VII. Antigens and Immunization. Lactate dehydrogenase B4 (Boehringer, Mannheim, Federal Republic of Germany) and poly(GluS°Ala 4°) (GA; Miles-Yeda, Rehovot, Israel) were prepared and the immunizations were performed as described previously (16, 21) .
Antisera. The culture supernatants of hybridomas 1147 (anti-Lyt-1.1) and 49-31.1 (antiLyt-2.1) were a gift from Dr. I. F. C. McKenzie (Department of Pathology, University of Melbourne, Parkville, Victoria, Australia). Ascites fluids containing high-titered monoclonal antibodies were produced using the hybridomas 17/-27.R7 (anti-Ia.m5), 13/18 (anti-Ia.m7), H116-22.R7 (anti-H-2.ml), 19-178 (anti-Lyt-2.2) (22) (the hybridomas were obtained from Dr. G. J. H~mmerling, German Cancer Research Center, Heidelberg, Federal Republic of Germany), and C3PO (anti-Lyt-l.2, produced in this laboratory). Anti-I-J k alloantiserum was purchased from Cedarline, Hornby, Ontario, Canada.
Cell Preparation. Single cell suspensions prepared from the inguinal and paraortic lymph nodes were passed through nylon wool columns; ~95% of the effluent cells were Thy-l.2 +, as detected by indirect immunofluorescence. Glass-adherent cells from peritoneal washings served as APC (23) .
Treatment of Cells with Antibody and Complement. Cells were treated with Lyt-specific antibodies and rabbit complement in a one-stage test, as described previously (24) . Anti-I-J k serum was used according to the producer's instructions.
Preparative, Nonlytic Selection of Lyt Subsets. Cells of the Lyt-l+2 -subset were selected by incubation of T cells with Lyt-2-specific antibody at 0°C for 1 h, followed by incubation of cells on goat anti-mouse immunoglobulin (Ig) (Medac GmbH, Hamburg, Federal Republic of Germany)-coated plastic dishes at 4°C for 1 h (25) . The nonadherent cells were >94% Lyt-l+2 -(as assessed by indirect immunofluorescence with rat Lyt-speeific monoclonal antibodies). The adherent cells were further selected by incubation with Lyt-l-specifie antibody, followed by plating on fresh anti-mouse Ig-coated dishes. After this second plating, the adherent cells were ~98% Lyt-1+2 +.
Cell Cultures. The culture medium was RPMI 1640 supplemented with 5% horse serum, antibiotics, L-glutamine, and 2-mercaptoethanol (26) . Priming of T cell subsets in vitro was carried out by culturing 4 × 10 s cells/ml of T cells with 1-2 × 106 cells/ml of syngeneic APC in the presence of 15 btg/ml LDHB for 3 d, followed by incubation for 4 d without antigen. In some experiments, in vivo primed selected T cell subsets were restimulated in bulk culture with LDHB and fresh APC.
Short-Term Incubation of Tse with Th or Tsi. Lyt-1+2 +, J+ cells that had been primed in vivo (8 d) and restimulated in vitro (3 d) or primed and restimulated in vitro (8 + 3 d) were mixed in culture medium with Lyt-1 +2-, J-, or Lyt-1 +2-cells at ratios of 1:1 or 1:2 and incubated at 37°C for 6 h. After incubation, the cell subset to be assayed was selected by Lyt-2 antibody plus rabbit complement (C) (Lyt-l+2 -) or by positive selection with Lyt-2 antibody (Lyt-l+2+).
Depletion of Alloreactive T Cells and Priming of T Cells with Antigen on Allogeneic APC. These were performed as described previously (23) . Briefly, splenic T cells were cultured with allogeneic peritoneal adherent cells, and, after 3 d, alloreactive cells were removed by treatment with 5-bromo-2'-deoxyuridine (BudR) and light. The surviving T cells were then incubated with LDHn (15 gg/ml) and fresh allogeneic APC for 3 d and without antigen for a further 4 d. The T Cell Proliferation Assay. This was performed as described previously (21) . Monoclonal antibodies, when present, were included in the same volume (0.2 ml) of culture. Each experimental group was set up in 3 to 15 parallel cultures. The standard deviation rarely exceeded 10%. The results are expressed as ~ cpm, that is cpm in cultures with APC plus LDHB minus cpm in cultures with APC, and stimulation index (SI), that is, cpm in cultures with APC plus LDHB divided by cpm in cultures with APC. In experiments involving groups of different cell mixtures, A cpm and SI were determined for each individual cell mixture.
Results
The Ts Effector (Tse) Cell Is Lyt-l+2+,J +. We have previously shown (16, 20) that primed T cells from nonresponder mice, when depleted of Lyt-2-bearing ceils, can proliferate upon in vitro challenge with LDHB. Thus, at least one T cell subset involved in the suppression of anti-LDHB response expresses the Lyt-2 marker. To characterize this subset, we separated different Lyt-subsets from nonresponder (C3H) mice by nonlytic selection and tested their mixtures for proliferation in a secondary response. The results in Table I vivo or in vitro, did not suppress the response (unpublished data). Thus, these results identify an Lyt-l+2 +, J+ cell that suppresses the proliferative anti-LDHB response of an Lyt-l+2 -, J-(presumably Th) cell.
The Lyt-l+2 + Tse Is E Restricted in Both the Induction and the Effector Phase. We have repeatedly demonstrated that the coating of the E u molecule with monoclonal antibodies prevents LDHmspecifie suppression from occurring (16) (17) (18) 20 , and Table  I ). We have also shown (20) that priming of B10.A(2R) (KkAkEkD~ T cells with LDH~ presented on APC from the Ek-nonexpressor strain B10.A(4R) (KkAkE°D ~) does not lead to suppression (20) . Taken together, these data provide strong evidence that recognition of LDHB in the context of E k molecules on APC is required for the generation of suppression. It has remained to be established which cells (and at what stage of their development) require antigen presentation in the context ofE k molecules. This question was partially addressed by the experiments in Table I and fully explored by those in Table II . The latter data show that blocking of the E molecule with antibody, either during priming of the Lyt-l+2 + cells, or at their effector phase, abolishes suppression. Antibodies against class I (K) or the class II (A) molecules are ineffective. (The A-specific antibody, however, blocks the proliferation of Lyt-l+2 -cells; see also Table I ). Thus, it is the Lyt-l+2 + Tse that requires antigen presentation in the context of E k molecules for both its induction and its effector function.
The Interaction between Tse and Th Cells Is Restricted by the A Region of the H-2 Complex.
We found in preliminary experiments that a short-term (6 h) incubation of Th cells with Tse cells (followed by removal of Tse cells) is sufficient to abolish the proliferation of Th cells in a subsequen t 3-d assay. We have chosen this technique to investigate the genetics of Th-Tse interaction because it eliminates complicating allogeneic effects. Thus, Tse (Lyt-1+2 +) cells primed in vivo and restimulated in vitro were incubated for 6 h with Th (Lyt-l+2 -, J-) cells from different strains; the Tse cells were then killed with anti-Lyt-2 antibody and C, and the Th cells were tested for antigen-specific proliferation. The genetic mapping of Tse-Th cell interaction is summarized in Table III A cpm, S1 (Table IV) . Both cell populations were incubated with B 10.A(2R) Tse cells (Lyt-1+2 +) for 6 h, the Tse cells were then removed by anti-Lyt-2.2 and (2 treatment, and the Th cells were tested for antigen-specific proliferation. The results in Table IV demonstrate The Lyt-l+2+,J + Tse Requires a Nonspecific Lyt-l+2-,J + Ts-inducer (Tsi) Cell. Thus far, the results have demonstrated that the Lyt-l+2 + Tse can be primed with LDHB presented by Ek-expressing AP(2 in the absence of other T cell sets. This cell, therefore, seems to be more autonomous than the Tse of other suppressor systems, which require a series of inductive cell interactions to become activated (3). We have, however, not ruled out the possibility that after antigen priming, the Tse receives an additional signal provided by the Lyt-l+2 -cells in secondary cultures. To investigate this possibility, we compared the ability of Tse cells to suppress Lyt-1 +2-and Lyt-1 ÷2-, J-(treated with anti-J k + C) cells, respectively. As seen in Table V (and also in Table I ), in vivo primed Tse are capable of suppressing the response of Lyt-l+2 -and of Lyt-l+2 -, J-cells equally well. In contrast, in vitro primed Lyt-l+2 + cells exert their suppressor function only in the presence of Lyt-l+2 -, J+ cells (Table V) . Thus, to become functional, in vitro primed Tse requires a second signal provided by an Lyt-l+2 -, J+ Tsi cell. Because Tse from immunized mice can suppress Th in the absence of Tsi, it is likely that in this case the Tsi-Tse interaction occurred in vivo. We investigated whether antigen is required for the activation of the Lyt-l+2 -, J+ Tsi cells. The results in Table VI show that Lyt-l+2 -cells from nonimmunized mice or from mice immunized with LDHB or GA serve equally well as inducers of the LDHB-specific Tse. Thus, the Tsi cells in the LDHB system appear to be nonspecific.
TABLE IV The Restriction Specificity of Th Cells Determines the Interaction between Th and Tse Cells

Absence of Genetic Restriction in the Interaction between Tsi and Tse Cells.
The short-term cell-mixing protocol applied for the studies of Th-Tse interaction (Table III) was also used to establish the genetic requirements for interaction between Tsi and Tse cells (Table VII) . Lyt-1+2 + Tse cells from B 10.AL mice were primed in vitro and incubated for 6 h with Lyt-l+2 -(Tsi) cells from different strains. The Tse cells were then positively selected with Lyt-2.2 antibody and incubated for a further 6 h with primed syngeneic Th (Lyt-l+2 -, J-) cells. After the second incubation, the Tse cells were killed with anti-Lyt-2.2 antibody and C, and the Th cells were tested for antigenspecific proliferation in a 3-d assay. The data in Table VII demonstrate 
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Tse cell interaction is independent of both the H-2 complex and the non-H-2 background; in other words, the interaction is unrestricted.
Discussion
Based on the data in this communication, the LDHB suppressor pathway can be summarized, as shown in Fig. 1 . At first glance, this pathway appears to be different from other suppressor pathways described thus far, first, in its simplicity, second, in that the antigen must be presented to the Tse cell in the context of E molecules, and third, in the involvement of a nonspecific Tsi cell. However, a closer analysis of the known suppressor pathways suggests that these differences may be more seeming than real.
With regard to the first difference, we would like to point out that the suppressor pathways involved in the regulation of antibody responses to SRBC (1), poly(Glun°Alaa°Tyr x°) (GAT), poly(Glur~ryr 5°) (GT) (2, 3) , and keyhole limpet he- mocyanin (KLH) (26) actually consist, as does the LDHB-specific pathway, of only two cells. Although in two pathways, the GAT-specific and the SRBC-specific ones, a third Lyt-1-2 + cell has been implicated, it has not been determined whether it is a distinct cell, or whether it has arisen from the second, Lyt-l+2 + cell, by a phenotype change. Thus, all known regulatory pathways of antibody responses appear to be bicellular, in contrast to the delayed-type hypersensitivity suppressor pathways that seem to involve three cells (2, 3) .
The second seemingly unique feature of the LDHB pathway is the requirement for the antigen to be presented to the Tse cells in the context of E molecules. It should be emphasized, however, that in all pathways, triggering of the second cell in the pathway (Ts2) requires antigen (1, 26-28) in addition to the signal provided by TSl (Tsi) cells. It is, therefore, conceivable that antigen presentation may play a role at the level of Ts2 induction, although this aspect has not yet been explored in the other systems. In fact, we found another example for E-restricted suppression in the immune response to IgG2a myeloma proteins (16) . Furthermore, it is possible that the mechanism behind the control of anti-GT response by two complementing Is genes (29) is E-restricted suppression because the Is-gene complementation is very similar to that required for the cell-membrane expression of E molecules (30) .
The third difference between the LDHB pathway and other known suppressor pathways is that the Tsi cell is nonspecific in the former and apparently antigenspecific in the latter. However, a direct comparison of inducer cells in the pathways is hampered by the insufficiency of information on these cells. For example, the Ysa cells in the GAT, GT, and KLH systems have not yet been isolated. The antigen specificity of inducer cells in the GAT, GT, and SRBC systems is extrapolated from the specificity of inducer factors extracted from lymphoid cells of immunized mice (28, 31, 32) . Control experiments to test the inducer activity of Tsi cells cultured with an unrelated antigen or without antigen have not been reported. These examples illustrate the prematurity of attempts at establishing similarities or differences between different suppressor pathways.
Our data have also provided some information about the mechanisms of interactions between cells of the LDHB suppressor pathway. The mechanism by which Tsi cells activate Tse cells has not yet been studied in detail. It is, however, likely that this activation occurs via a nonspecific factor, which may be similar to interleukin 2 (33). This assumption is based on the observations that, first, the Tsi cell does not require specific activation by antigen; second, it acts on Tse cells after the latter have been primed; and third, the action of Tsi on Tse cells is unrestricted. The interaction between Tse and Th cells is more difficult to visualize. This interaction is antigen specific (20; and C. Baxevanis, unpublished data) and MHC restricted (Table III) . Because the interacting cells themselves are also antigen specific and MHC restricted, the interaction is not likely to be based on the recognition of idiotypic determinants. The key information for understanding the Tse-Th cell interaction is that the A restriction of this interaction is dictated by the receptor (anti-A k) of the Th cells (Table IV' ). Thus, in terms of recognition, the active party is the Th and not the Tse cell. Considering also that the interaction is antigen specific and A restricted, its simplest mechanism would be a concomitant recognition of LDHB and A regioncontrolled molecules by Th cells on the surface of Tse cells. This recognition would trigger a suppressor mechanism, for example, the production of a short-range sup-pressor factor, that inactivates the Th cell. The mechanism outlined here requires, first, the recognition by Th and Tse of two different epitopes on the LDHB molecule (that is, formation of an antigen bridge), and second, the expression of A molecules by Tse cells. We are presently investigating whether these two requirements are met.
Summary
We characterized the cell types involved in the H-2-controlled suppression of T cell response to lactate dehydrogenase B (LDHB). The suppressor effector (Tse) was found to be an Lyt-l+2 +, J+ cell that recognizes antigen together with E k molecules of antigen-presenting cells (APC). To become functional, the Tse cell requires a second signal from a nonspecific, Lyt-l+2 -, J+ suppressor-inducer (Tsi) cell. The Tsi-Tse interaction is not subject to any genetic restriction. The target cell of suppression is an Lyt-1 +2-, J-(most likely T helper [Th] ) cell that recognizes LDHB in the context of A molecules on APC. The suppression is manifested in inhibition of the antigenspecific, A-restricted proliferation of Th cells. The interaction between Tse and Th is restricted by the A region of the H-2 complex. Because this restriction is determined by the receptor of Th cells, the mechanism of Th-Tse interaction most likely involves a concomitant recognition of LDHB and A region-controlled molecules by Th cells on the surface of Tse cells.
